These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18639901)

  • 61. Re: Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-AnalysisA. Pilatz, K. Dimitropoulos, R. Veeratterapillay, Y. Yuan, M. I. Omar, S. MacLennan, T. Cai, F. Bruyère, R. Bartoletti, B. Köves, F. Wagenlehner, G. Bonkat and B. Pradere
    Jazayeri SB; Balaji KC
    J Urol; 2020 Dec; 204(6):1349-1350. PubMed ID: 32830995
    [No Abstract]   [Full Text] [Related]  

  • 62. Re: Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance: F. Zhao, E. Olkhov-Mitsel, T. van der Kwast, J. Sykes, D. Zdravic, V. Venkateswaran, A. R. Zlotta, A. Loblaw, N. E. Fleshner, L. Klotz, D. Vesprini and B. Bapat J Urol 2017;197:335-341.
    Zhao F; Jeyapala R; Olkhov-Mitsel E; Vesprini D; Fleshner NE; Bapat B
    J Urol; 2018 May; 199(5):1354-1355. PubMed ID: 29428633
    [No Abstract]   [Full Text] [Related]  

  • 63. Re: Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology: A. Priester, S. Natarajan, P. Khoshnoodi, D. J. Margolis, S. S. Raman, R. E. Reiter, J. Huang, W. Grundfest and L. S. Marks J Urol 2017;197:320-326.
    Yan W; Shang Z; Zhou Z
    J Urol; 2017 Sep; 198(3):708-709. PubMed ID: 28577379
    [No Abstract]   [Full Text] [Related]  

  • 64. Re: Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology: A. Priester, S. Natarajan, P. Khoshnoodi, D. J. Margolis, S. S. Raman, R. E. Reiter, J. Huang, W. Grundfest and L. S. Marks J Urol 2017;197:320-326.
    Orczyk C; Emberton M
    J Urol; 2017 Dec; 198(6):1436-1437. PubMed ID: 28888772
    [No Abstract]   [Full Text] [Related]  

  • 65. Re: Personalized Risks of Over Diagnosis for Screen Detected Prostate Cancer Incorporating Patient Comorbidities: Estimation and CommunicationR. Gulati, S. P. Psutka and R. Etzioni
    Shah N; Ioffe V
    J Urol; 2020 Apr; 203(4):841-842. PubMed ID: 31845839
    [No Abstract]   [Full Text] [Related]  

  • 66. Re: Nerli RB, Ghagane SC, Rangrez S, Chandra S, Thakur ML, Gomella L. Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors. Indian J Urol 2021;37:345-9.
    Pattnaik SS
    Indian J Urol; 2022; 38(1):77-78. PubMed ID: 35136303
    [No Abstract]   [Full Text] [Related]  

  • 67. Author Reply Re: Nerli RB, Ghagane SC, Rangrez S, Chandra S, Thakur ML, Gomella L. Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors. Indian J Urol 2021;37:345-9.
    Nerli RB; Ghagane SC; Rangrez SS; Chandra S; Thakur ML; Gomella L
    Indian J Urol; 2022; 38(1):78-79. PubMed ID: 35136304
    [No Abstract]   [Full Text] [Related]  

  • 68. Contrast enhanced ultrasound guidance: a new tool to improve accuracy in percutaneous biopsies.
    Spârchez Z; Radu P; Zaharia T; Kacso G; Grigorescu I; Badea R
    Med Ultrason; 2010 Jun; 12(2):133-8. PubMed ID: 21173941
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies.
    Linden RA; Trabulsi EJ; Forsberg F; Gittens PR; Gomella LG; Halpern EJ
    J Urol; 2007 Dec; 178(6):2354-8. PubMed ID: 17936814
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ultrasound for prostate imaging and biopsy.
    Ismail M; Gomella LG
    Curr Opin Urol; 2001 Sep; 11(5):471-7. PubMed ID: 11493767
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transrectal ultrasonography and ultrasound-guided biopsies of the prostate gland: how, when, and where.
    Papatheodorou A; Ellinas P; Tandeles S; Takis F; Poulias H; Nikolaou I; Batakis N
    Curr Probl Diagn Radiol; 2005; 34(2):76-83. PubMed ID: 15753881
    [No Abstract]   [Full Text] [Related]  

  • 72. Re: Factors predicting prostatic biopsy Gleason sum under grading: D. A. Stackhouse, L. Sun, F. R. Schroeck, J. Jayachandran, A. A. Caire, C. O. Acholo, C. N. Robertson, D. M. Albala, T. J. Polascik, C. F. Donatucci, K. E. Maloney and J. W. Moul J Urol 2009; 182: 118-124.
    Labanaris AP; Kühn R; Zugor V
    J Urol; 2010 Jan; 183(1):396-7; author reply 397-8. PubMed ID: 19945124
    [No Abstract]   [Full Text] [Related]  

  • 73. The influence of prostate volume on prostate cancer detection using a combined approach of contrast-enhanced ultrasonography-targeted and systematic grey-scale biopsy.
    Colleselli D; Bektic J; Schaefer G; Frauscher F; Mitterberger M; Brunner A; Schwentner C; Bartsch G; Horninger W; Pelzer AE
    BJU Int; 2007 Dec; 100(6):1264-7. PubMed ID: 17850369
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Re: Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies. R. A. Linden, E. J. Trabulsi, F. Forsberg, P. R. Gittens, L. G. Gomella and E. J. Halpern. J Urol 2007; 178: 2354-2358.
    Prakash G; Gautam G
    J Urol; 2008 Sep; 180(3):1184; author reply 1184-5. PubMed ID: 18639901
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.